[Chronic pain due to degenerative and inflammatory musculoskeletal diseases in the elderly. Observational study investigating dosage, course of treatment, effectiveness and tolerability of tilidine/naloxone].
von Renteln-Kruse
W
W
Chefarzt Medizinisch-Geriatrische Klinik, Albertinen-Haus, Sellhopsweg 18-22, D-22459 Hamburg.
Sarnow
E
E
Schenkel
I
I
D000368:Aged; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D018771:Arthralgia / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006801:Humans; D008875:Middle Aged; D009140:Musculoskeletal Diseases / Q000188:drug therapy*; D009270:Naloxone / Q000009:adverse effects / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy*; D010147:Pain Measurement; D017060:Patient Satisfaction; D013993:Tilidine / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D004338:Drug Combinations; C026862:Valoron N; D009270:Naloxone; D013993:Tilidine